Evaluation of Therapeutic Drug Monitoring in the Clinical Management of Patients with Rheumatic Diseases: Data from a Retrospective Single-Center Cohort Study
Lise Pedersen, 1 Pal Bela Szecsi, 1 Per Birger Johansen, 2 Poul Jannik Bjerrum 1 1Department of Clinical Biochemistry, University of Copenhagen, Holbæk Hospital, Holbæk, Denmark; 2Department of Rheumatology, University of Copenhagen, Holbæk Hospital, Holbæk,...
Guardado en:
Autores principales: | Pedersen L, Szecsi PB, Johansen PB, Bjerrum PJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ce6c057476541f09ee7202709315479 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
por: E. V. Voronina, et al.
Publicado: (2018) -
A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
por: Byron P. Vaughn
Publicado: (2021) -
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
por: Alvisi P, et al.
Publicado: (2019) -
Systematic review of immunomodulatory therapies for hidradenitis suppurativa
por: Lim SYD, et al.
Publicado: (2019) -
Eficacia y seguimiento en el largo plazo de pacientes con psoriasis vulgar moderada a severa en tratamiento con infliximab (Remicade®)
por: Valdés A,María del Pilar, et al.
Publicado: (2006)